MaxCyte, Inc. ( MXCT) - Key Metrics
MXCT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.07 | -$0.08 | -$0.04 | -$0.04 |
| 2026Q1 | $0.09 | -$0.04 | -$0.08 | -$0.08 |
| 2025Q4 | $0.07 | -$0.09 | -$0.03 | -$0.03 |
| 2025Q3 | $0.06 | -$0.12 | -$0.07 | -$0.07 |
| 2025Q2 | $0.08 | -$0.12 | -$0.09 | -$0.10 |
MXCT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.84 |
| 2026Q1 | 0% | -3.96 |
| 2025Q4 | 0% | -4.31 |
| 2025Q3 | 0% | -3.29 |
| 2025Q2 | 0% | -4.54 |
MXCT
Price: $1.01
52 week price:
Earnings Per Share: -0.34 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 508900
Market Capitalization: 114.6 million